期刊文献+

冠心舒通胶囊对急性心肌梗死大鼠心功能作用的实验研究 被引量:4

The effects and the mechanism of total flavonoids of choerspondias axillaris fructus on cardiac function of acute myocardial infarction rats
下载PDF
导出
摘要 目的 探讨冠心舒通胶囊对急性心肌梗死大鼠心功能的作用及其机制.方法 采用结扎大鼠左前降支的方法 制备急性心肌梗死大鼠模型,用1.4 F微导管和BL-420多道生理记录仪测量对照组、急性心肌梗死模型组及冠心舒通胶囊组左室压(LVP)及左室内压最大变速率(dp/dt).结果 急性心肌梗死大鼠模型的心肌收缩力指标LVP和dp/dt明显低于正常对照组(P<0.01,n=7),而冠心舒通胶囊可明显改善心肌缺血大鼠心脏的血流动力学参数指标,并且有一定的剂量依赖性(P<0.05,n=7).结论 冠心舒通胶囊可以改善急性心肌梗死大鼠模型心功能. Objective To study the effect of totalflavonoids of astragalus on function of acute myocardial infarction rats. Methods The rats which were subjected to left anterior descending coronary artery ligation were applied to compare the effect of cardiac function of total flavonoids of choerspondias axillaris fructus rats with the control group. Results The LVP and dp/dt of the rats which were subjected to left anterior descending coronary artery ligation were lower than that of the control group (P〈0.01, n=7 ),the total flavonoids of choerspondias axillaris fructus could enhance the cardiac function of the rats of acute myocardial infarction with dose dependent (P〈 0.05,n=7 ). Conclusion The total flavonoids of choerspondias axillaris fructus could enhance the cardiac function of the rats of acute myocardial infarction
出处 《中国心血管病研究》 CAS 2010年第12期944-946,共3页 Chinese Journal of Cardiovascular Research
关键词 冠心舒通胶囊 心肌梗死 心功能 Total flavonoids of choerspondias axillaris fruetus Myocardial infarction Cardiac function
  • 相关文献

参考文献8

二级参考文献19

  • 1[1]Rosamond W,Flegal K,Friday G,et al.Heart Disease and Stroke Slat-istics-2007 Update:a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.Circulation,2007,115:e69-e171.
  • 2[3]Cleland JG,Swedberg K,Follath F,et al.Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology.Eur Heart J.The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe.Part 1:patient characteristics and diagnosis.Eur Heart J,2003,24:442-463.
  • 3[4]Siirila-waris K,Lassos J,Melin J,et al.Characteristics,outcomes,and predictors of 1-year mortality in patients hospitalized for acute heart failure.Eur Heart J,2006,27:3011-3017.
  • 4[5]Nieminen MS,Brutsaert D,Diekstein K,et al,EuroHeart Survey Invest-igators:Heart Failure Association,European Society of Cardiology.EuroHeart Failure Survey Ⅱ(EHFS Ⅱ):a survey on hospitalized acute heart failure patients:description of population.Eur Heart J,2006,27:2725-2736.
  • 5[6]Gheorghiade M,Abraham WT,Albert NM,et al.OPTIMIZE-HF Investigators and Coordinators.Systolic blood pressure at admission,clinical characteristics,and outcomes in patients hospitalized with acute heart failure.JAMA,2006,296:2217-2226.
  • 6[7]Peacock WF 4th,De Marco T,Fonarow GC,et al.ADHERE Investigators.Cardiac troponin and outcome in acute heart failure.N Engl J Mad,2008,358:2117-2126.
  • 7[8]Mogelvang R,Goetze JP,Schnohr P,et al.Copenhagen City Heart Study.Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma pro-B-type natriuretic peptide.J Am Coll Cardiol,2007,50:1694-1701.
  • 8[9]Maisel A.Circulating natriuretic peptide levels in acute heart failure.Rev Cardiovasc Med,2007,8(Suppl 5):S13-21.
  • 9[10]Cleland JG,Coletta AP,Abdellah AT,et al.Clinical trials update from the American Heart Association 2006:OAT,SALT 1 and 2,MAGIC,ABCD,PABA-CHF,IMPROVE-CHF.and percutaneous mitral armuloplesty.Eur J Heart Fail,2007,9:92-97.
  • 10[11]Brenden CK,Hollander JE,Guss D,et al,Gray zone BNP levels heart failure patients in the emergency department:results from the Rapid Emergency Department Heart Failure Outpatient Trial(REDHOT)multicenter study.Am Heart J,2006,151:1013-1018.

共引文献47

同被引文献51

引证文献4

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部